nimacimab glp-1 news The initiation of our CBeyond™ Phase 2 trial marks exactly one year since the transformational acquisition of Bird Rock Bio and the strategic positioning of $SKYE at the forefront of metabolic health Skye's CB1-blocking obesity drug fails
Pay in 4 interest-free payments of $5.75 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6



























